- Home
- LRE vs HOOK Comparison
LRE vs HOOK Comparison
Compare LRE & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRE
- HOOK
- Stock Information
- Founded
- LRE 2001
- HOOK 2011
- Country
- LRE Japan
- HOOK United States
- Employees
- LRE N/A
- HOOK N/A
- Industry
- LRE
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- LRE
- HOOK Health Care
- Exchange
- LRE Nasdaq
- HOOK Nasdaq
- Market Cap
- LRE 18.3M
- HOOK 18.1M
- IPO Year
- LRE 2023
- HOOK 2019
- Fundamental
- Price
- LRE $1.25
- HOOK $0.92
- Analyst Decision
- LRE
- HOOK Buy
- Analyst Count
- LRE 0
- HOOK 4
- Target Price
- LRE N/A
- HOOK $10.67
- AVG Volume (30 Days)
- LRE 2.6K
- HOOK 51.1K
- Earning Date
- LRE 01-01-0001
- HOOK 05-08-2025
- Dividend Yield
- LRE N/A
- HOOK N/A
- EPS Growth
- LRE N/A
- HOOK N/A
- EPS
- LRE 0.29
- HOOK N/A
- Revenue
- LRE $117,804,154.00
- HOOK $43,946,000.00
- Revenue This Year
- LRE N/A
- HOOK N/A
- Revenue Next Year
- LRE N/A
- HOOK N/A
- P/E Ratio
- LRE $4.20
- HOOK N/A
- Revenue Growth
- LRE 8.82
- HOOK 118.32
- 52 Week Low
- LRE $1.10
- HOOK $0.88
- 52 Week High
- LRE $13.76
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- LRE 50.02
- HOOK 22.10
- Support Level
- LRE $1.19
- HOOK $1.17
- Resistance Level
- LRE $1.26
- HOOK $1.24
- Average True Range (ATR)
- LRE 0.04
- HOOK 0.09
- MACD
- LRE 0.03
- HOOK -0.00
- Stochastic Oscillator
- LRE 82.37
- HOOK 7.88
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.